Evaluating the developmental toxicity of trypanocidal nitroaromatic compounds on zebrafish

Acta Tropica

Volumn 128, Issue 3, 2013, Pages 701-705

  Buchanan Kilbey, Grace ^a   Djumpah, Joshua ^a   Papadopoulou, Maria V ^b   Bloomer, William ^b   Hu, Lonqin ^c   Wilkinson, Shane R ^a   Ashworth, Rachel ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

Development; Protozoa; Toxicity; Trypanosome; Zebrafish

Indexed keywords

ANTITRYPANOSOMAL AGENT; BENZNIDAZOLE; LH 34; LH 37; NIFURTIMOX; NITROBENZYL PHOSPHORAMIDE MUSTARD; UNCLASSIFIED DRUG;

CYPRINID; DRUG; EMBRYONIC DEVELOPMENT; ORGANIC COMPOUND; PROTOZOAN; TOXICITY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEVELOPMENTAL TOXICITY; EDEMA; EMBRYO; EMBRYO DEATH; NONHUMAN; PHENOTYPE; PIGMENT DISORDER; SWIMMING; TOXICITY TESTING; TRYPANOSOMIASIS; ZEBRA FISH;

DANIO RERIO; PROTOZOA;

DEVELOPMENT; PROTOZOA; TOXICITY; TRYPANOSOME; ZEBRAFISH;

ANIMALS; DRUG EVALUATION, PRECLINICAL; EMBRYO, NONMAMMALIAN; HIGH-THROUGHPUT SCREENING ASSAYS; NIFURTIMOX; NITROIMIDAZOLES; TRYPANOCIDAL AGENTS; ZEBRAFISH;

EID: 84892490567     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2013.07.022     Document Type: Article

References (20)

1. Ashworth R., Zimprich F., Bolsover S.R. Buffering intracellular calcium disrupts motoneuron development in intact zebrafish embryos. Developmental Brain Research 2001, 129:169-179.
2. Brennan C., Mangoli M., Dyer C.E., Ashworth R. Acetylcholine and calcium signalling regulates muscle fibre formation in the zebrafish embryo. Journal of Cell Science 2005, 118:5181-5190.
3. Castro J.A., de Mecca M.M., Bartel L.C. Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis). Human and Experimental Toxicology 2006, 25:471-479.
4. Castro J.A., Diaz de Toranzo E.G. Toxic effects of nifurtimox and benznidazole, two drugs used against American trypanosomiasis (Chagas' disease). Biomedical and Environmental Sciences 1988, 1:19-33.
5. Chico T.J., Ingham P.W., Crossman D.C. Modeling cardiovascular disease in the zebrafish. Trends in Cardiovascular Medicine 2008, 18:150-155.
6. Hall B.S., Wu X., Hu L., Wilkinson S.R. Exploiting the drug-activating properties of a novel trypanosomal nitroreductase. Antimicrobial Agents and Chemotherapy 2010, 54:1193-1199.
7. Hu L., Wu X., Han J., Chen L., Vass S.O., Browne P., Hall B.S., Bot C., Gobalakrishnapillai V., Searle P.F., Knox R.J., Wilkinson S.R. Synthesis and structure-activity relationships of nitrobenzyl phosphoramide mustards as nitroreductase-activated prodrugs. Bioorganic and Medicinal Chemistry Letters 2011, 21:3986-3991.
8. Hu L., Yu C., Jiang Y., Han J., Li Z., Browne P., Race P.R., Knox R.J., Searle P.F., Hyde E.I. Nitroaryl phosphoramides as novel prodrugs for E. coli nitroreductase activation in enzyme prodrug therapy. Journal of Medicinal Chemistry 2003, 46:4818-4821.
9. Kimmel C.B., Ballard W.W., Kimmel S.R., Ullman B., Schilling T.F. Stages of embryonic development of the zebrafish. Developmental Dynamics 1995, 203:253-310.
10. Nemtsas P., Wettwer E., Christ T., Weidinger G., Ravens U. Adult zebrafish heart as a model for human heart? An electrophysiological study. Journal of Molecular and Cellular Cardiology 2010, 48:161-171.
11. Papadopoulou M.V., Bloomer W.D., Rosenzweig H.S., Chatelain E., Kaiser M., Wilkinson S.R., McKenzie C., Ioset J.R. Novel 3-nitro-1H-1,2,4-triazole-based amides and sulfonamides as potential antitrypanosomal agents. Journal of Medicinal Chemistry 2012, 55:5554-5565.
12. Papadopoulou M.V., Trunz B.B., Bloomer W.D., McKenzie C., Wilkinson S.R., Prasittichai C., Brun R., Kaiser M., Torreele E. Novel 3-nitro-1H-1,2,4-triazole-based aliphatic and aromatic amines as anti-chagasic agents. Journal of Medicinal Chemistry 2012, 54:8214-8223.
13. Peterson R.T., Macrae C.A. Systematic approaches to toxicology in the zebrafish. Annual Review of Pharmacology and Toxicology 2012, 52:433-453.
14. Rinkwitz S., Mourrain P., Becker T.S. Zebrafish: an integrative system for neurogenomics and neurosciences. Progress in Neurobiology 2011, 93:231-243.
15. Westerfield M. The Zebrafish Book: A Guide for the Laboratory Use of Zebrafish (Brachydanio rerio) 1995, Univ. of Oregon Press, Eugene. 3rd ed.
16. Wilkinson S.R., Kelly J.M. Trypanocidal drugs: mechanisms, resistance and new targets. Expert Reviews in Molecular Medicine 2009, 11:e31.
17. Wilkinson S.R., Taylor M.C., Horn D., Kelly J.M., Cheeseman I. A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:5022-5027.
18. Yang L., Ho N.Y., Alshut R., Legradi J., Weiss C., Reischl M., Mikut R., Liebel U., Muller F., Strahle U. Zebrafish embryos as models for embryotoxic and teratological effects of chemicals. Reproductive Toxicology 2009, 28:245-253.
19. Zhou L., Ishizaki H., Spitzer M., Taylor K.L., Temperley N.D., Johnson S.L., Brear P., Gautier P., Zeng Z., Mitchell A., Narayan V., McNeil E.M., Melton D.W., Smith T.K., Tyers M., Westwood N.J., Patton E.E. ALDH2 mediates 5-nitrofuran activity in multiple species. Chemistry and Biology 2012, 19:883-892.
20. Zon L.I., Peterson R.T. In vivo drug discovery in the zebrafish. Nature Reviews Drug Discovery 2005, 4:35-44.